2025 Somanath EASD Icovamenib and Semaglutide Combo Therapy Enhances Body Weight Loss and Glycemic Control While Preserving Lean Mass

Biomea Fusion Inc. published this content on September 16, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 16, 2025 at 16:57 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]